Anzeige
Mehr »
Login
Samstag, 02.11.2024 Börsentäglich über 12.000 News von 674 internationalen Medien
Technischer Ausbruch: Diese Kupferaktie ist in den letzten 52 Wochen um 300 % gestiegen! Der Durchbruch läuft!
Anzeige

Indizes

Kurs

%
News
24 h / 7 T
Aufrufe
7 Tage

Aktien

Kurs

%
News
24 h / 7 T
Aufrufe
7 Tage

Xetra-Orderbuch

Fonds

Kurs

%

Devisen

Kurs

%

Rohstoffe

Kurs

%

Themen

Kurs

%

Erweiterte Suche

WKN: A2DYN5 | ISIN: CA23809L1085 | Ticker-Symbol: D4G
Tradegate
31.10.24
21:06 Uhr
0,006 Euro
+0,001
+26,09 %
Branche
Hardware
Aktienmarkt
Sonstige
1-Jahres-Chart
DATAMETREX AI LIMITED Chart 1 Jahr
5-Tage-Chart
DATAMETREX AI LIMITED 5-Tage-Chart
RealtimeGeldBriefZeit
0,0010,01001.11.
0,0030,00601.11.
ACCESSWIRE
268 Leser
Artikel bewerten:
(1)

Datametrex AI Ltd.: Imagine Health Welcomes New Physicians and Resumes Accepting New Patients

TORONTO, ON / ACCESSWIRE / October 30, 2024 / Datametrex AI Limited (the "Company" or "Datametrex") (TSXV:DM)(FSE:D4G)(OTC PINK:DTMXF) is pleased to announce that its Imagine Health Centres ("ImagineHealth" or "IHC") clinics in Calgary and Edmonton resumed accepting new patients, supported by the addition of several new physicians across both locations. For new patients interested in accessing care, the Company encourages patients to contact each clinic directly. The Calgary clinic can be reached at +1 (403) 775-9669 and for those in Edmonton, please contact the clinic at +1 (780) 468-5999. Both clinics can be reached via email at info@imaginehealthcentres.com. IHC team is ready to assist you in finding the right physician to meet your healthcare needs, and look forward to welcoming you to Imagine Health Centres.

IHC Calgary Downtown:

The Calgary clinic has welcomed an expanded team of physicians to meet the needs of the community. Dr. Matthew Kerslake, a walk-in physician and Certified PrEP (Pre-Exposure Prophylaxis) Prescriber, is available Monday through Thursday from 9:00 AM to 5:00 PM, providing consistent walk-in care throughout the week. Dr. John Haddad and Dr. Ingrid Cheung offer additional walk-in support, with Dr. Haddad available on Tuesdays and Fridays and Dr. Cheung on Mondays, Tuesdays, and Thursdays. Family Physician Dr. Elham Rezaeisarlak is accepting new patients and is available Monday through Thursday, delivering dedicated, personalized family care. Dr. Rachel Han, who is fluent in Korean, is available for walk-in patients on Wednesdays and Fridays, broadening access for diverse patient needs.

IHC Edmonton:

In Edmonton, Imagine Health welcomes Dr. Renata Mishra, a Family Physician with a specialization in women's health. Dr. Mishra is available Monday, Tuesday, and Thursday and accepts referrals for women's health concerns, including IUD insertions.

"We are excited to welcome these dedicated physicians to Imagine Health and to expand our ability to meet the healthcare needs of patients in Calgary and Edmonton," said Paul Haber, CEO of Datametrex. "With a strong commitment to accessible and comprehensive care, we look forward to continuing to grow Imagine Health and to serving our communities with the highest standard of medical care."

Patients seeking walk-in services, specialized care, or a new family physician are invited to visit Imagine Health and experience the expanded range of healthcare offerings. For more information or to book an appointment, please contact the respective clinic.

Commitment to Healthcare Accessibility

By expanding its medical team, Datametrex reaffirms its commitment to improving healthcare accessibility and enhancing patient outcomes. The Company remains focused on providing comprehensive healthcare solutions that respond to the evolving needs of Canadians.

About Datametrex

Datametrex is an innovative leader in Technology Solutions, Artificial Intelligence, Healthcare, and Mobile Gaming. The Company excels in delivering tools and solutions that enhance operational efficiencies and business outcomes. With a commitment to innovation, Datametrex is dedicated to supporting enterprises by setting a new standard for business protocols through cutting-edge technology.

For more on Datametrex, please visit our YouTube channel and Company website.

For Additional Information

Paul Haber, C.P.A., C.A., C.Dir
CEO & Chairman
info@datametrex.com
(416) 318-6501

Neither TSX Venture Exchange nor its Regulation Services Provider (as that term is defined in the policies of the TSX Venture Exchange) accepts responsibility for the adequacy or accuracy of this release.

Forward-Looking Statements

This news release contains "forward-looking statements," which involve risks, uncertainties, and factors that could cause actual results to differ materially from those anticipated. These statements are not historical facts and are generally identified by words such as "expects," "plans," "anticipates," "believes," "intends," "estimates," "projects," and similar expressions. Such statements include expectations related to game development and other Company plans.

While Datametrex believes the forward-looking information is reasonable as of the date of this release, these statements involve assumptions, risks, and uncertainties that could cause actual outcomes to differ. Key factors include general economic conditions, legislative and regulatory developments, access to capital, industry competition, and the Company's ability to execute its strategies. The Company does not undertake to update these statements, except as required by law. Readers are advised not to place undue reliance on forward-looking information.

Factors that could cause actual results to differ materially are detailed under "Risk Factors" in Datametrex's management's discussion and analysis for the year ended December 31, 2023, available on the Company's profile at www.sedarplus.ca.

This release does not constitute an offer to sell or a solicitation to buy, nor shall it constitute an offer, solicitation, or sale in any jurisdiction where such would be unlawful prior to registration or qualification under applicable securities laws. We seek Safe Harbor.

SOURCE: Datametrex AI Ltd.



View the original press release on accesswire.com

© 2024 ACCESSWIRE
Tenbagger-Chance mit der nächsten BioNTech

Erinnern Sie sich, als Moderna und BioNTech von unbekannten Unternehmen zu globalen Marktführern wurden und frühzeitige Investoren reich belohnt haben?

Die Branche steht vor einem erneuten Innovationsschub – von bahnbrechenden Medikamenten bis hin zu revolutionären Therapien.

Warum sollten Sie dabei sein?

Sie sollten jetzt in Biotech-Aktien einsteigen, weil wir am Beginn einer neuen Ära der medizinischen Innovation stehen könnten! Gen- und Zelltherapien, personalisierte Medizin und bahnbrechende Technologien könnten das Gesundheitswesen revolutionieren – und die Aktienkurse in die Höhe schießen lassen.

Die nächste Erfolgsgeschichte im Biotechbereich warten nur darauf, entdeckt zu werden. Wer jetzt investiert, hat die Chance, von gigantischen Durchbrüchen und enormen Renditen zu profitieren. Warten Sie nicht, bis es zu spät ist - der nächste Biotech-Superstar könnte morgen schon durchstarten!

Verpassen Sie nicht diese Chance!

Fordern Sie sofort unseren brandneuen Biotech-Spezialreport an und erfahren Sie, welche 3 Biotech-Aktien das riesige Potenzial haben, Ihren finanziellen Erfolg zu sichern. Dieser Report ist komplett kostenlos und zeigt Ihnen zukunftsträchtige Investments im Biotech-Sektor.

Handeln Sie jetzt und sichern Sie sich Ihren kostenfreien Report!

Werbehinweise: Die Billigung des Basisprospekts durch die BaFin ist nicht als ihre Befürwortung der angebotenen Wertpapiere zu verstehen. Wir empfehlen Interessenten und potenziellen Anlegern den Basisprospekt und die Endgültigen Bedingungen zu lesen, bevor sie eine Anlageentscheidung treffen, um sich möglichst umfassend zu informieren, insbesondere über die potenziellen Risiken und Chancen des Wertpapiers. Sie sind im Begriff, ein Produkt zu erwerben, das nicht einfach ist und schwer zu verstehen sein kann.